72 related articles for article (PubMed ID: 15026035)
1. The synthesis and structure-activity relationships of 3-amino-4-benzylquinolin-2-ones; discovery of novel KCNQ2 channel openers.
Hewawasam P; Chen N; Ding M; Natale JT; Boissard CG; Yeola S; Gribkoff VK; Starrett J; Dworetzky SI
Bioorg Med Chem Lett; 2004 Apr; 14(7):1615-8. PubMed ID: 15026035
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationship of acrylamides as KCNQ2 potassium channel openers.
Wu YJ; He H; Sun LQ; L'Heureux A; Chen J; Dextraze P; Starrett JE; Boissard CG; Gribkoff VK; Natale J; Dworetzky SI
J Med Chem; 2004 May; 47(11):2887-96. PubMed ID: 15139767
[TBL] [Abstract][Full Text] [Related]
3. C-terminal interaction of KCNQ2 and KCNQ3 K+ channels.
Maljevic S; Lerche C; Seebohm G; Alekov AK; Busch AE; Lerche H
J Physiol; 2003 Apr; 548(Pt 2):353-60. PubMed ID: 12640002
[TBL] [Abstract][Full Text] [Related]
4. Identification, synthesis, and activity of novel blockers of the voltage-gated potassium channel Kv1.5.
Peukert S; Brendel J; Pirard B; Brüggemann A; Below P; Kleemann HW; Hemmerle H; Schmidt W
J Med Chem; 2003 Feb; 46(4):486-98. PubMed ID: 12570371
[TBL] [Abstract][Full Text] [Related]
5. KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions: expansion of the functional and mutation spectrum.
Singh NA; Westenskow P; Charlier C; Pappas C; Leslie J; Dillon J; Anderson VE; Sanguinetti MC; Leppert MF;
Brain; 2003 Dec; 126(Pt 12):2726-37. PubMed ID: 14534157
[TBL] [Abstract][Full Text] [Related]
6. (S)-N-[1-(3-morpholin-4-ylphenyl)ethyl]- 3-phenylacrylamide: an orally bioavailable KCNQ2 opener with significant activity in a cortical spreading depression model of migraine.
Wu YJ; Boissard CG; Greco C; Gribkoff VK; Harden DG; He H; L'Heureux A; Kang SH; Kinney GG; Knox RJ; Natale J; Newton AE; Lehtinen-Oboma S; Sinz MW; Sivarao DV; Starrett JE; Sun LQ; Tertyshnikova S; Thompson MW; Weaver D; Wong HS; Zhang L; Dworetzky SI
J Med Chem; 2003 Jul; 46(15):3197-200. PubMed ID: 12852750
[TBL] [Abstract][Full Text] [Related]
7. 4-Aryl-3-(hydroxyalkyl)quinolin-2-ones: novel maxi-K channel opening relaxants of corporal smooth muscle targeted for erectile dysfunction.
Hewawasam P; Fan W; Ding M; Flint K; Cook D; Goggins GD; Myers RA; Gribkoff VK; Boissard CG; Dworetzky SI; Starrett JE; Lodge NJ
J Med Chem; 2003 Jul; 46(14):2819-22. PubMed ID: 12825925
[TBL] [Abstract][Full Text] [Related]
8. Analogs of a potent maxi-K potassium channel opener with an improved inhibitory profile toward cytochrome P450 isozymes.
Vrudhula VM; Dasgupta B; Boissard CG; Gribkoff VK; Santone KS; Dalterio RA; Lodge NJ; Starrett JE
Bioorg Med Chem Lett; 2005 Oct; 15(19):4286-90. PubMed ID: 16061379
[TBL] [Abstract][Full Text] [Related]
9. Four novel tarantula toxins as selective modulators of voltage-gated sodium channel subtypes.
Bosmans F; Rash L; Zhu S; Diochot S; Lazdunski M; Escoubas P; Tytgat J
Mol Pharmacol; 2006 Feb; 69(2):419-29. PubMed ID: 16267209
[TBL] [Abstract][Full Text] [Related]
10. 4-Aryl-3-(mercapto)quinolin-2-ones: novel maxi-K channel opening relaxants of corporal smooth muscle.
Hewawasam P; Fan W; Cook DA; Newberry KS; Boissard CG; Gribkoff VK; Starrett J; Lodge NJ
Bioorg Med Chem Lett; 2004 Sep; 14(17):4479-82. PubMed ID: 15357975
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial potassium channels.
Szewczyk A; Jarmuszkiewicz W; Kunz WS
IUBMB Life; 2009 Feb; 61(2):134-43. PubMed ID: 19165895
[TBL] [Abstract][Full Text] [Related]
12. N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): a novel, selective KCNQ2/Q3 potassium channel activator.
Wickenden AD; Krajewski JL; London B; Wagoner PK; Wilson WA; Clark S; Roeloffs R; McNaughton-Smith G; Rigdon GC
Mol Pharmacol; 2008 Mar; 73(3):977-86. PubMed ID: 18089837
[TBL] [Abstract][Full Text] [Related]
13. External barium affects the gating of KCNQ1 potassium channels and produces a pore block via two discrete sites.
Gibor G; Yakubovich D; Peretz A; Attali B
J Gen Physiol; 2004 Jul; 124(1):83-102. PubMed ID: 15226366
[TBL] [Abstract][Full Text] [Related]
14. Peripheral nerve hyperexcitability due to dominant-negative KCNQ2 mutations.
Wuttke TV; Jurkat-Rott K; Paulus W; Garncarek M; Lehmann-Horn F; Lerche H
Neurology; 2007 Nov; 69(22):2045-53. PubMed ID: 17872363
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological activity of pyrazolo[1,5-a]pyrimidin-7(4H)-ones as novel Kv7/KCNQ potassium channel activators.
Qi J; Zhang F; Mi Y; Fu Y; Xu W; Zhang D; Wu Y; Du X; Jia Q; Wang K; Zhang H
Eur J Med Chem; 2011 Mar; 46(3):934-43. PubMed ID: 21296466
[TBL] [Abstract][Full Text] [Related]
16. Atropisomeric 3-(beta-hydroxyethyl)-4-arylquinolin-2-ones as Maxi-K potassium channel openers.
Vrudhula VM; Dasgupta B; Qian-Cutrone J; Kozlowski ES; Boissard CG; Dworetzky SI; Wu D; Gao Q; Kimura R; Gribkoff VK; Starrett JE
J Med Chem; 2007 Mar; 50(5):1050-7. PubMed ID: 17274609
[TBL] [Abstract][Full Text] [Related]
17. The synthesis and structure-activity relationships of 4-aryl-3-aminoquinolin-2-ones: a new class of calcium-dependent, large conductance, potassium (maxi-K) channel openers targeted for post-stroke neuroprotection.
Hewawasam P; Fan W; Knipe J; Moon SL; Boissard CG; Gribkoff VK; Starrett JE
Bioorg Med Chem Lett; 2002 Jul; 12(13):1779-83. PubMed ID: 12067560
[TBL] [Abstract][Full Text] [Related]
18. Conserved gating hinge in ligand- and voltage-dependent K+ channels.
Magidovich E; Yifrach O
Biochemistry; 2004 Oct; 43(42):13242-7. PubMed ID: 15491131
[TBL] [Abstract][Full Text] [Related]
19. Inwardly rectifying and voltage-gated outward potassium channels exhibit low sensitivity to methylmercury.
Yuan Y; Otero-Montañez JK; Yao A; Herden CJ; Sirois JE; Atchison WD
Neurotoxicology; 2005 Jun; 26(3):439-54. PubMed ID: 15935214
[TBL] [Abstract][Full Text] [Related]
20. An essential function of phosphatidylinositol phosphates in activation of plant shaker-type K+ channels.
Liu K; Li L; Luan S
Plant J; 2005 May; 42(3):433-43. PubMed ID: 15842627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
